Variant report

Variant	nsv594203
Chromosome Location	chr4:54960005-55030375
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:336)
CpG islands
(count:2445)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:336 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:54965895-54966138	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr4:54975548-54976321	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr4:54970101-54970253	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr4:54967190-54967334	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr4:54966415-54966709	H1-hESC	embryonic stem cell:	n/a	n/a
6	BHLHE40	chr4:54966219-54966404	HepG2	liver:	n/a	chr4:54966277-54966290 chr4:54966279-54966288 chr4:54966280-54966289 chr4:54966279-54966288
7	BRCA1	chr4:54970014-54970262	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr4:54977120-54977336	IMR90	lung:	n/a	chr4:54977247-54977258
9	CEBPB	chr4:55017884-55018090	IMR90	lung:	n/a	n/a
10	CEBPB	chr4:54966450-54966770	IMR90	lung:	n/a	n/a
11	CEBPB	chr4:55029527-55029771	A549	lung:	n/a	chr4:55029647-55029658
12	CEBPB	chr4:54985051-54985246	HepG2	liver:	n/a	chr4:54985185-54985196
13	CEBPB	chr4:55029511-55029801	HepG2	liver:	n/a	chr4:55029647-55029658
14	CEBPB	chr4:54977097-54977372	HepG2	liver:	n/a	chr4:54977247-54977258
15	CEBPB	chr4:54964937-54965245	IMR90	lung:	n/a	chr4:54965084-54965095 chr4:54965082-54965093
16	CEBPB	chr4:54986780-54986983	IMR90	lung:	n/a	chr4:54986874-54986885
17	CEBPB	chr4:54986729-54987029	K562	blood:	n/a	chr4:54986874-54986885
18	CEBPB	chr4:54985657-54985833	IMR90	lung:	n/a	n/a
19	CEBPB	chr4:55029489-55029824	IMR90	lung:	n/a	chr4:55029647-55029658
20	CEBPB	chr4:54986704-54987025	HepG2	liver:	n/a	chr4:54986874-54986885
21	CEBPB	chr4:54966585-54966639	HepG2	liver:	n/a	n/a
22	CEBPB	chr4:54964956-54965180	K562	blood:	n/a	chr4:54965084-54965095 chr4:54965082-54965093
23	CEBPB	chr4:54966471-54966475	H1-hESC	embryonic stem cell:	n/a	n/a
24	CEBPB	chr4:54986766-54987010	A549	lung:	n/a	chr4:54986874-54986885
25	CEBPB	chr4:54964924-54965260	HepG2	liver:	n/a	chr4:54965084-54965095 chr4:54965082-54965093
26	CEBPB	chr4:55029503-55029784	K562	blood:	n/a	chr4:55029647-55029658
27	CEBPB	chr4:54964932-54965263	H1-hESC	embryonic stem cell:	n/a	chr4:54965084-54965095 chr4:54965082-54965093
28	CEBPB	chr4:54975510-54975851	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr4:54977181-54977301	A549	lung:	n/a	chr4:54977247-54977258
30	CEBPB	chr4:54985029-54985350	IMR90	lung:	n/a	chr4:54985185-54985196
31	CHD1	chr4:54969984-54970012	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD1	chr4:54975547-54975779	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD1	chr4:54973652-54974387	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD2	chr4:54975788-54976122	H1-hESC	embryonic stem cell:	n/a	n/a
35	CHD2	chr4:54966531-54966578	H1-hESC	embryonic stem cell:	n/a	n/a
36	CHD2	chr4:54969820-54970328	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD2	chr4:54970398-54970411	HepG2	liver:	n/a	n/a
38	CHD2	chr4:54967504-54967804	H1-hESC	embryonic stem cell:	n/a	n/a
39	CREB1	chr4:54966330-54966649	H1-hESC	embryonic stem cell:	n/a	n/a
40	CREB1	chr4:54966254-54966770	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTBP2	chr4:54964983-54968272	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTBP2	chr4:54960819-54961139	H1-hESC	embryonic stem cell:	n/a	n/a
43	CTBP2	chr4:54962630-54963206	H1-hESC	embryonic stem cell:	n/a	n/a
44	CTBP2	chr4:54973247-54974537	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTBP2	chr4:54959507-54960524	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTBP2	chr4:54968833-54970616	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTBP2	chr4:54974945-54976224	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr4:54974520-54974670	HCFaa	heart:	n/a	n/a
49	CTCF	chr4:54974620-54974770	GM06990	blood:	n/a	n/a
50	CTCF	chr4:54974600-54974750	AG04450	lung:	n/a	n/a

(count:2445 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:54967809-54967859	HRCEpiC	kidney:	n/a
2	chr4:54960226-54960276	NH-A	brain:	n/a
3	chr4:54965904-54965954	HAEpiC	amniotic membrane:	n/a
4	chr4:54974644-54974694	AG09309	skin:	n/a
5	chr4:54963174-54963224	AG04450	lung:	fetal
6	chr4:54967809-54967859	HRCEpiC	kidney:	n/a
7	chr4:54960226-54960276	NH-A	brain:	n/a
8	chr4:54965904-54965954	HAEpiC	amniotic membrane:	n/a
9	chr4:54974644-54974694	AG09309	skin:	n/a
10	chr4:54963174-54963224	AG04450	lung:	fetal
11	chr4:54967674-54967724	HMEC	breast:	n/a
12	chr4:55019140-55019190	AG04450	lung:	fetal
13	chr4:54967423-54967473	MCF10A-Er-Src	breast:	n/a
14	chr4:54974644-54974694	ProgFib	skin:	n/a
15	chr4:54970254-54970304	AG04450	lung:	fetal
16	chr4:54965904-54965954	AG04449	skin:	fetal
17	chr4:54975593-54975643	AG10803	skin:	n/a
18	chr4:55019140-55019190	GM12891	blood:	n/a
19	chr4:54961835-54961885	ECC-1	luminal epithelium:	n/a
20	chr4:54974644-54974694	HPAEpiC	pulmonary alveolar:	n/a
21	chr4:54960259-54960309	SKMC	muscle:	n/a
22	chr4:54975677-54975727	HIPEpiC	eye:	n/a
23	chr4:54965999-54966049	NH-A	brain:	n/a
24	chr4:54975894-54975944	SAEC	small airway:	n/a
25	chr4:54961835-54961885	PANC-1	pancreas:	n/a
26	chr4:54976184-54976234	HEK293	kidney:	embryo
27	chr4:54960972-54961022	HCPEpiC	choroid plexus:	n/a
28	chr4:54967674-54967724	GM12878	blood:	n/a
29	chr4:54967674-54967724	Jurkat	blood:	n/a
30	chr4:54974644-54974694	NH-A	brain:	n/a
31	chr4:54969963-54970013	SK-N-SH	brain:	n/a
32	chr4:54967809-54967859	Caco-2	colon:	n/a
33	chr4:54975894-54975944	HMEC	breast:	n/a
34	chr4:54965829-54965879	Caco-2	colon:	n/a
35	chr4:54967809-54967859	ovcar-3	ovarian:	n/a
36	chr4:54965999-54966049	LNCaP	prostate:	n/a
37	chr4:54969963-54970013	HCPEpiC	choroid plexus:	n/a
38	chr4:54975250-54975300	HMEC	breast:	n/a
39	chr4:54961668-54961718	PFSK-1	brain:	n/a
40	chr4:54960232-54960282	HAEpiC	amniotic membrane:	n/a
41	chr4:54975250-54975300	HEK293	kidney:	embryo
42	chr4:54966990-54967040	BE2_C	brain:	n/a
43	chr4:54963174-54963224	NT2-D1	testis:	n/a
44	chr4:54963174-54963224	AG10803	skin:	n/a
45	chr4:54967423-54967473	T-47D	breast:	n/a
46	chr4:55019140-55019190	MCF10A-Er-Src	breast:	n/a
47	chr4:54960232-54960282	HEEpiC	esophagus:	n/a
48	chr4:54965999-54966049	PrEC	prostate:	n/a
49	chr4:54969609-54969659	HNPCEpiC	eye:	n/a
50	chr4:54974682-54974732	CMK	blood:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:54967560..54969215-chr4:55017035..55019730,2	K562	blood:
2	chr4:54966084..54968498-chr4:54968560..54970883,2	MCF-7	breast:
3	chr4:54966084..54968498-chr4:54968560..54970883,2	MCF-7	breast:
4	chr4:55011296..55011796-chr9:131873114..131873945,2	Hela-S3	cervix:
5	chr4:54825736..54828574-chr4:54972078..54973978,2	K562	blood:
6	chr4:54967560..54969215-chr4:55017035..55019730,2	K562	blood:
7	chr4:54962971..54965791-chr4:54975162..54976964,2	K562	blood:

No data

Variant related genes	Relation type
GSX2	TF binding region
ENSG00000238753	TF binding region
ENSG00000221219	TF binding region
GSX2	CpG island
ENSG00000238753	CpG island
ENSG00000221219	CpG island
ENSG00000180613	chromatin interactions
ENSG00000095321	chromatin interactions
ENSG00000221219	chromatin interactions
ENSG00000119383	chromatin interactions

Extended variants
information (count: 1825 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:1825 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13116880	chr4:54960005-54960006	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs368784497	chr4:54960021-54960022	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs565199247	chr4:54960026-54960027	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs545984562	chr4:54960052-54960053	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs79039111	chr4:54960070-54960071	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs567509106	chr4:54960116-54960117	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs540770241	chr4:54960163-54960164	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs530261286	chr4:54960177-54960178	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs530059628	chr4:54960231-54960232	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs375283913	chr4:54960232-54960233	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs566874525	chr4:54960259-54960260	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs538989375	chr4:54960327-54960328	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs558689025	chr4:54960346-54960347	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs571518842	chr4:54960385-54960386	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs537334386	chr4:54960403-54960404	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs557328669	chr4:54960427-54960428	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs548600835	chr4:54960430-54960431	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs143812704	chr4:54960448-54960449	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs553001938	chr4:54960471-54960472	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs146857457	chr4:54960523-54960524	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs544944702	chr4:54960529-54960530	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs6835520	chr4:54960553-54960554	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs574932428	chr4:54960576-54960577	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs544485553	chr4:54960587-54960588	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs10652258	chr4:54960615-54960616	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs33962000	chr4:54960621-54960622	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs3068171	chr4:54960627-54960628	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs76051084	chr4:54960628-54960629	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs148974689	chr4:54960637-54960638	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs375334916	chr4:54960673-54960674	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs531828135	chr4:54960756-54960757	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs369395431	chr4:54960760-54960761	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs117742302	chr4:54960761-54960762	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs1346082	chr4:54960782-54960783	Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs560592031	chr4:54960808-54960809	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs532501440	chr4:54960829-54960830	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs552746101	chr4:54960839-54960840	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs376455832	chr4:54960885-54960886	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs142998763	chr4:54960906-54960907	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs151113830	chr4:54960913-54960914	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs560262930	chr4:54960972-54960973	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs528893841	chr4:54960990-54960991	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs73147718	chr4:54961011-54961012	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs536408962	chr4:54961013-54961014	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
45	rs547459725	chr4:54961045-54961046	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs573042528	chr4:54961055-54961056	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs538343708	chr4:54961077-54961078	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs183166701	chr4:54961102-54961103	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs542896953	chr4:54961112-54961113	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs574868540	chr4:54961129-54961130	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	19435819	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian neoplasms	16753589	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Glioblastoma multiforme	21569311	CNVD
Glioblastoma	17504929	CNVD
Glioblastoma	16823502	CNVD
Melanoma	16908931	CNVD
Glioblastoma	20031968	CNVD
Medulloblastoma	19270706	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Olfactory neuroblastoma	18408657	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Rhabdomyosarcoma	16790082	CNVD
Gastrointestinal stromal cancer	17438095	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	19208797	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	19115005	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21138945	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Cancer	17440070	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:1301 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:54958600-54960200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr4:54958600-54960200	Bivalent Enhancer	Fetal Heart	heart
3	chr4:54958600-54960400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
4	chr4:54958600-54960400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr4:54958600-54960600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
6	chr4:54958800-54960200	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
7	chr4:54958800-54960200	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
8	chr4:54958800-54960200	Weak transcription	Cortex derived primary cultured neurospheres	brain
9	chr4:54958800-54960200	Bivalent Enhancer	Fetal Thymus	thymus
10	chr4:54958800-54960200	Bivalent Enhancer	GM12878-XiMat	blood
11	chr4:54958800-54960400	Bivalent Enhancer	Fetal Intestine Large	intestine
12	chr4:54958800-54960400	Bivalent Enhancer	Fetal Intestine Small	intestine
13	chr4:54958800-54960600	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
14	chr4:54958800-54962800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr4:54958800-54965800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr4:54959000-54960600	Weak transcription	HSMMtube	muscle
17	chr4:54959000-54964400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr4:54959200-54960400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
19	chr4:54959400-54960200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
20	chr4:54959400-54960200	Bivalent Enhancer	Lung	lung
21	chr4:54959400-54960200	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
22	chr4:54959400-54960200	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
23	chr4:54959400-54960400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
24	chr4:54959400-54960400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
25	chr4:54959400-54960400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
26	chr4:54959400-54960400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
27	chr4:54959400-54960800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
28	chr4:54959600-54960400	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
29	chr4:54959600-54965600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
30	chr4:54959800-54960200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
31	chr4:54959800-54960400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
32	chr4:54959800-54960400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
33	chr4:54959800-54961600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
34	chr4:54960000-54960200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr4:54960000-54960200	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
36	chr4:54960000-54960200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
37	chr4:54960000-54960200	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
38	chr4:54960000-54960200	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
39	chr4:54960000-54960200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr4:54960000-54960200	Bivalent Enhancer	Fetal Stomach	stomach
41	chr4:54960000-54960200	Enhancers	Pancreas	Pancrea
42	chr4:54960000-54960400	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr4:54960000-54960600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
44	chr4:54960200-54960400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr4:54960200-54960400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
46	chr4:54960200-54960400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
47	chr4:54960200-54960400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
48	chr4:54960200-54960400	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
49	chr4:54960200-54960400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr4:54960200-54960400	Bivalent Enhancer	Colon Smooth Muscle	Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links